AHA: OIG Proposal Unlikely to Lower Drug Prices

A Department of Health and Human Services' Office of Inspector General proposal to change drug discount safe harbors under the federal anti-kickback statute would likely increase premiums for Medicare beneficiaries without addressing the nation's high and rising drug prices, the AHA said.

Related Resources

AHA Center for Health Innovation Market Scan
To understand what’s really driving Amazon's moves in pharmacy, it’s important to know the back story of Amazon’s $750 million-plus acquisition of PillPack, an…
Special Bulletin
Member
The Centers for Medicare…
Letter/Comment
Public
AHA applauds the U.S. House of Representatives for considering the Strengthening Health Care and Lowering Prescription Drug Costs Act.
Special Bulletin
Member
The Centers for Medicare…
Letter/Comment
Public
AHA letter to Senator Richard J.
Letter/Comment
Public
AHA letter to Ways and Means Committee on the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113.